Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung

K. B. Woo, T. P. Waalkes, M. D. Abeloff, Raymond Lenhard, C. W. Gehrke, K. C. Kuo

Research output: Contribution to journalArticle

Abstract

Clinical correlates with urinary excretion of polyamines were evaluated for 29 newly diagnosed and 35 previously treated patients with small cell carcinoma of the lung (SCC). The frequencies of pretreatment abnormalities were 12 (41%) for putrescine, 18 (62%) for spermidine, and 20 (69%) for spermine. In assessing disease parameters, the combined use of the abnormalities of spermidine and spermine as a discriminant was more effective than that of all three polyamines; it correlated significantly with extent of limited and extensive disease (P <0.001), and also resulted in significant separation of survival curves, the median survival of 11 months for both elevated compared to 19 months for neither or only one elevated (P = 0.062). No significant difference was seen in the abnormalities between no metastasis and one metastasis, whereas the frequencies of the abnormalities was highly increased in two or more metastases. The distribution of polyamines determined at regular treatment intervals showed distinctively more elevated patterns in progressive disease than in stable disease or partial and complete responses (P <0.01). In order to evaluate therapeutic effects on the relationship between polyamine excretion and tumor regression, correlations between urinary putrescine and spermidine were determined. The values of the ratio of spermidine to putrescine were significantly smaller in responders than in nonresponders (P <0.01); and these may be related to smaller tumor mass and higher tumor proliferative activity in responders, and larger tumor mass and lower tumor proliferative activity in nonresponders.

Original languageEnglish (US)
Pages (from-to)1684-1690
Number of pages7
JournalCancer
Volume52
Issue number9
StatePublished - 1983

Fingerprint

Small Cell Lung Carcinoma
Polyamines
Spermidine
Putrescine
Spermine
Neoplasms
Neoplasm Metastasis
Survival
Therapeutic Uses

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Woo, K. B., Waalkes, T. P., Abeloff, M. D., Lenhard, R., Gehrke, C. W., & Kuo, K. C. (1983). Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung. Cancer, 52(9), 1684-1690.

Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung. / Woo, K. B.; Waalkes, T. P.; Abeloff, M. D.; Lenhard, Raymond; Gehrke, C. W.; Kuo, K. C.

In: Cancer, Vol. 52, No. 9, 1983, p. 1684-1690.

Research output: Contribution to journalArticle

Woo, KB, Waalkes, TP, Abeloff, MD, Lenhard, R, Gehrke, CW & Kuo, KC 1983, 'Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung', Cancer, vol. 52, no. 9, pp. 1684-1690.
Woo, K. B. ; Waalkes, T. P. ; Abeloff, M. D. ; Lenhard, Raymond ; Gehrke, C. W. ; Kuo, K. C. / Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung. In: Cancer. 1983 ; Vol. 52, No. 9. pp. 1684-1690.
@article{d5d5dd919417417a8db79d5a0b5da9d1,
title = "Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung",
abstract = "Clinical correlates with urinary excretion of polyamines were evaluated for 29 newly diagnosed and 35 previously treated patients with small cell carcinoma of the lung (SCC). The frequencies of pretreatment abnormalities were 12 (41{\%}) for putrescine, 18 (62{\%}) for spermidine, and 20 (69{\%}) for spermine. In assessing disease parameters, the combined use of the abnormalities of spermidine and spermine as a discriminant was more effective than that of all three polyamines; it correlated significantly with extent of limited and extensive disease (P <0.001), and also resulted in significant separation of survival curves, the median survival of 11 months for both elevated compared to 19 months for neither or only one elevated (P = 0.062). No significant difference was seen in the abnormalities between no metastasis and one metastasis, whereas the frequencies of the abnormalities was highly increased in two or more metastases. The distribution of polyamines determined at regular treatment intervals showed distinctively more elevated patterns in progressive disease than in stable disease or partial and complete responses (P <0.01). In order to evaluate therapeutic effects on the relationship between polyamine excretion and tumor regression, correlations between urinary putrescine and spermidine were determined. The values of the ratio of spermidine to putrescine were significantly smaller in responders than in nonresponders (P <0.01); and these may be related to smaller tumor mass and higher tumor proliferative activity in responders, and larger tumor mass and lower tumor proliferative activity in nonresponders.",
author = "Woo, {K. B.} and Waalkes, {T. P.} and Abeloff, {M. D.} and Raymond Lenhard and Gehrke, {C. W.} and Kuo, {K. C.}",
year = "1983",
language = "English (US)",
volume = "52",
pages = "1684--1690",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung

AU - Woo, K. B.

AU - Waalkes, T. P.

AU - Abeloff, M. D.

AU - Lenhard, Raymond

AU - Gehrke, C. W.

AU - Kuo, K. C.

PY - 1983

Y1 - 1983

N2 - Clinical correlates with urinary excretion of polyamines were evaluated for 29 newly diagnosed and 35 previously treated patients with small cell carcinoma of the lung (SCC). The frequencies of pretreatment abnormalities were 12 (41%) for putrescine, 18 (62%) for spermidine, and 20 (69%) for spermine. In assessing disease parameters, the combined use of the abnormalities of spermidine and spermine as a discriminant was more effective than that of all three polyamines; it correlated significantly with extent of limited and extensive disease (P <0.001), and also resulted in significant separation of survival curves, the median survival of 11 months for both elevated compared to 19 months for neither or only one elevated (P = 0.062). No significant difference was seen in the abnormalities between no metastasis and one metastasis, whereas the frequencies of the abnormalities was highly increased in two or more metastases. The distribution of polyamines determined at regular treatment intervals showed distinctively more elevated patterns in progressive disease than in stable disease or partial and complete responses (P <0.01). In order to evaluate therapeutic effects on the relationship between polyamine excretion and tumor regression, correlations between urinary putrescine and spermidine were determined. The values of the ratio of spermidine to putrescine were significantly smaller in responders than in nonresponders (P <0.01); and these may be related to smaller tumor mass and higher tumor proliferative activity in responders, and larger tumor mass and lower tumor proliferative activity in nonresponders.

AB - Clinical correlates with urinary excretion of polyamines were evaluated for 29 newly diagnosed and 35 previously treated patients with small cell carcinoma of the lung (SCC). The frequencies of pretreatment abnormalities were 12 (41%) for putrescine, 18 (62%) for spermidine, and 20 (69%) for spermine. In assessing disease parameters, the combined use of the abnormalities of spermidine and spermine as a discriminant was more effective than that of all three polyamines; it correlated significantly with extent of limited and extensive disease (P <0.001), and also resulted in significant separation of survival curves, the median survival of 11 months for both elevated compared to 19 months for neither or only one elevated (P = 0.062). No significant difference was seen in the abnormalities between no metastasis and one metastasis, whereas the frequencies of the abnormalities was highly increased in two or more metastases. The distribution of polyamines determined at regular treatment intervals showed distinctively more elevated patterns in progressive disease than in stable disease or partial and complete responses (P <0.01). In order to evaluate therapeutic effects on the relationship between polyamine excretion and tumor regression, correlations between urinary putrescine and spermidine were determined. The values of the ratio of spermidine to putrescine were significantly smaller in responders than in nonresponders (P <0.01); and these may be related to smaller tumor mass and higher tumor proliferative activity in responders, and larger tumor mass and lower tumor proliferative activity in nonresponders.

UR - http://www.scopus.com/inward/record.url?scp=0020566291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020566291&partnerID=8YFLogxK

M3 - Article

C2 - 6311401

AN - SCOPUS:0020566291

VL - 52

SP - 1684

EP - 1690

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9

ER -